ZYME Q4 2018 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M-42.2% YoY

Gross Profit

$15M50.6% margin

Operating Income

$9M29.5% margin

Net Income

$9M32.1% margin

EPS (Diluted)

$0.29

QoQ Revenue Growth

+1308.2%

Cash Flow

Operating Cash Flow

$50M

Free Cash Flow

$50M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$244M

Total Liabilities

$64M

Stockholders' Equity

$180M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$50M	-42.2%
Gross Profit	$15M	$38M	-61.5%
Operating Income	$9M	$33M	-74.4%
Net Income	$9M	$33M	-71.7%

Revenue Segments

Service, Other

$279,000100%